Real estate
The Australian biotech market, which was valued at nearly $23 billion last year, is expected to see some positive growth to $25.2 billion by 2025, according to a GlobalData analysis.
Alexandria Real Estate Equities, an urban office real estate investment company specializing in the life sciences, is expanding its Alexandria LaunchLabs into the East Cambridge, Massachusetts area.
Pfizer has signed a 20-year lease for its new company global headquarters. It will be, as reported earlier, at The Spiral, an office tower being built by Tishman Speyer at 66 Hudson Boulevard at Hudson Yards of Manhattan.
Teva Pharmaceuticals will close its offices in Washington, D.C. and New York City as part of the cost-cutting measures.
The new campus will consolidate some 400 employees in one place and give more space to the startup companies it helps.
This week MA-based real estate firm Calare Properties acquired the land and buildings for $5M.
ImmunoGen gave a pipeline progress report and 2017 operating results last week.
Moriarty and Wagner will not be making the move to Boston and will be leaving the company at the end of this month.
Beijing’s Tsinghua University will invest $276M in a JV to build a new biohub in the UK’s Cambridge Science Park.
The Dutch healthcare giant said that it also plans to invest in a service training program in Cleveland.
PRESS RELEASES